Accuray To Participate at J.P. Morgan's 39th Annual Healthcare Conference

Accuray Incorporated (Nasdaq: ARAY) will participate in the 39th J.P.

Rhea-AI Summary

Accuray Incorporated (Nasdaq: ARAY) will participate in the 39th J.P. Morgan Annual Healthcare Conference on January 14, 2021, at 11:00 am Pacific / 2:00 pm Eastern. Josh Levine, President and CEO, is set to present. The presentation can be accessed on Accuray's official website post-event. Institutional investors are invited to arrange one-on-one virtual meetings with senior management during the conference. Accuray is dedicated to advancing radiation therapy solutions for complex medical cases.

Argus Session date unavailable

+8.93% session move Open Argus

Details

News Market Reaction – ARAY

The recorded move for ARAY in the trading session of this news was +8.93%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SUNNYVALE, Calif., Jan. 6, 2021 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced its participation in the 39^th J.P. Morgan Annual Healthcare Conference. Josh Levine, President and CEO, is scheduled to present on Thursday, January 14, 2021 at 11:00 am PACIFIC / 2:00 pm EASTERN.

The presentation to be delivered at the J.P. Morgan Healthcare Conference can be accessed on the Accuray website at www.accuray.com/investors following the conclusion of Mr. Levine's talk.

To arrange one-on-one virtual meetings with Accuray senior management during the conference, institutional investors can contact their J.P. Morgan representative or email Joe Diaz with Accuray Investor Relations at jdiaz@accuray.com.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.

Investor Contacts
Lytham Partners
Joe Diaz
+1 (602) 889-9700
jdiaz@accuray.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/accuray-to-participate-at-jp-morgans-39th-annual-healthcare-conference-301201611.html

SOURCE Accuray Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Accuray's presentation at the J.P. Morgan Annual Healthcare Conference?

Accuray's presentation is scheduled for January 14, 2021, at 11:00 am Pacific / 2:00 pm Eastern.

Who is presenting for Accuray at the conference?

Josh Levine, the President and CEO of Accuray, will be presenting.

How can I access Accuray's presentation?

The presentation can be accessed on Accuray's website after the conclusion of the talk.

Can investors arrange meetings with Accuray's management during the conference?

Yes, institutional investors can contact their J.P. Morgan representative or email Joe Diaz for one-on-one meetings.

What is Accuray focusing on in their radiation therapy solutions?

Accuray focuses on providing innovative radiation therapy solutions for oncology and neuro-radiosurgery.